» Articles » PMID: 22219610

LPS-induced Migration of Peritoneal B-1 Cells is Associated with Upregulation of CXCR4 and Increased Migratory Sensitivity to CXCL12

Overview
Specialty General Medicine
Date 2012 Jan 6
PMID 22219610
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

B-1 cells, which constitute a predominant lymphocyte subset in serosal cavities and produce most of natural antibodies, are subdivided into the CD5(+) B-1a and CD5(-) B-1b cell subpopulations, but the differential roles of B-1a and B-1b cells are not well understood. We report that B-1a cells preferentially migrate out of the peritoneal cavity and upregulate the expression of CXCR4 with heightened sensitivity to CXCL12 and CXCL13 upon LPS treatment compared to B-1b and B-2 cells. Whereas B-1a cells were slightly more abundant than B-1b and B-2 cells in the homeostatic condition, the number of B-1a cells preferentially decreased 48 hr after LPS treatment. The decrease in the peritoneal B-1a cell number was accompanied with increased migration of B-1a cells toward CXCL-12 and CXCL-13 in in vitro transmigration assay using peritoneal B cells from LPS treated mice. The expression level of CXCR4, but not of CXCR5, was also more prominently increased in B-1a cells upon LPS stimulation. LPS-stimulated B-1a cells did not accumulate in omental milky spots in contrast to B-2 cells. These results suggest that B-1a cells actively migrate out of the peritoneal cavity through the regulation of the migratory responsiveness to chemokines and actively participate in systemic immune responses.

Citing Articles

Sphingosine-1-phosphate receptor type 4 is critically involved in the regulation of peritoneal B-1 cell trafficking and distribution in vivo.

Riese J, Kleinwort A, Hannemann M, Hahnel C, Kersting S, Schulze T Eur J Immunol. 2024; 54(12):e2350882.

PMID: 39344245 PMC: 11628879. DOI: 10.1002/eji.202350882.


B lymphocytes in COVID-19: a tale of harmony and discordance.

Mansourabadi A, Aghamajidi A, Dorfaki M, Keshavarz F, Shafeghat Z, Moazzeni A Arch Virol. 2023; 168(5):148.

PMID: 37119286 PMC: 10147999. DOI: 10.1007/s00705-023-05773-y.


In vitro sepsis up-regulates Nociceptin/Orphanin FQ receptor expression and function on human T- but not B-cells.

Bird M, Hebbes C, Tamang A, Willets J, Thompson J, Guerrini R Br J Pharmacol. 2023; 180(17):2298-2314.

PMID: 37021779 PMC: 10953342. DOI: 10.1111/bph.16088.


IL-10 Producing B Cells Protect against LPS-Induced Murine Preterm Birth by Promoting PD1- and ICOS-Expressing T Cells.

Busse M, Zenclussen A Cells. 2022; 11(17).

PMID: 36078100 PMC: 9454497. DOI: 10.3390/cells11172690.


Therapeutic Potential of B-1a Cells in Intestinal Ischemia-Reperfusion Injury.

Royster W, Ochani M, Aziz M, Wang P J Surg Res. 2021; 268:326-336.

PMID: 34399355 PMC: 8678159. DOI: 10.1016/j.jss.2021.06.070.


References
1.
Glodek A, Honczarenko M, Le Y, Campbell J, Silberstein L . Sustained activation of cell adhesion is a differentially regulated process in B lymphopoiesis. J Exp Med. 2003; 197(4):461-73. PMC: 2193869. DOI: 10.1084/jem.20021477. View

2.
Nogueira-Martins M, Mariano M . B-1 cell participation in T-cell-mediated alloimmune response. Immunobiology. 2009; 215(4):264-74. DOI: 10.1016/j.imbio.2009.05.007. View

3.
Baumgarth N . The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol. 2010; 11(1):34-46. DOI: 10.1038/nri2901. View

4.
Montecino-Rodriguez E, Leathers H, Dorshkind K . Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006; 7(3):293-301. DOI: 10.1038/ni1301. View

5.
Palmesino E, Moepps B, Gierschik P, Thelen M . Differences in CXCR4-mediated signaling in B cells. Immunobiology. 2006; 211(5):377-89. DOI: 10.1016/j.imbio.2005.12.003. View